logo

For the Inventor, By the Inventor

Stanford, CA, United States of America

David Seelig

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Tesla, Inc.. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Seelig. Retrieved from https://idiyas.com/inventor/david-seelig-q4y0ou1z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0


Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal2 out of 606 
 
Tesla, Inc.
 patents

Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents
1. 12164310 - Autonomous and user controlled vehicle summon to a target (2024-12-10),
2. 11567514 - Autonomous and user controlled vehicle summon to a target (2023-01-31),

Title: The Innovative Mind of David Seelig

Introduction: David Seelig is a renowned inventor based in Stanford, CA (US) known for his groundbreaking contributions to various fields.

Latest Patents: David Seelig holds several patents in the areas of technology, healthcare, and sustainability, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, David Seelig has worked on numerous projects that have revolutionized industries and improved people's lives.

Collaborations: Throughout his career, David Seelig has collaborated with leading companies, research institutions, and universities to bring his innovative ideas to life.

Conclusion: David Seelig's passion for innovation and his dedication to creating impactful solutions make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…